Thermo Fisher seeks immuno-oncology research grant proposals

By The Science Advisory Board staff writers

June 16, 2021 -- Thermo Fisher Scientific is accepting clinical research project submissions in immuno-oncology for its Oncomine Clinical Research Grant program.

The program funds molecular profiling studies that focus on the effect of immune-based treatments for cancer patients. Chosen research teams will be awarded with up to $200,000 in reagents and general funding.

Since its launch in 2020, the grant has been awarded to eight projects worldwide, supporting research in areas including fusion genes detection in solid cancer and hemato-oncology.

Proposals must be submitted to the program by July 16.

Copyright © 2021
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here